Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02639065
Title A Study of Durvalumab (MEDI4736) in Esophageal Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Shadia Jalal, MD
Indications

esophagus adenocarcinoma

Therapies

Durvalumab

Age Groups: adult
Covered Countries USA


No variant requirements are available.